CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Trough level of infliximab is useful for assessing mucosal healing in Crohn's disease: a prospective cohort study
Akihiro Koga, Toshiyuki Matsui, Noritaka Takatsu, Yasumichi Takada, Masahiro Kishi, Yutaka Yano, Takahiro Beppu, Yoichiro Ono, Kazeo Ninomiya, Fumihito Hirai, Takashi Nagahama, Takashi Hisabe, Yasuhiro Takaki, Kenshi Yao, Hirotsugu Imaeda, Akira Andoh
Intest Res. 2018;16(2):223-232.   Published online April 30, 2018
DOI: https://doi.org/10.5217/ir.2018.16.2.223

Excel Download

Trough level of infliximab is useful for assessing mucosal healing in Crohn's disease: a prospective cohort study
Intestinal Research. 2018;16(2):223   Crossref logo
Link1 Link2 Link3

Mucosal healing with methotrexate in Crohn’s disease: a prospective comparative study with azathioprine and infliximab
Alimentary Pharmacology & Therapeutics. 2011;33(6):714-721   Crossref logo
Link1

W1121 Clinical Efficacy and Mucosal Healing Rate of Infliximab in Steroid-Dependent Ulcerative Colitis: A Prospective Long-Term Follow-Up Study
Gastroenterology. 2009;136(5):A-658   Crossref logo
Link1 Link2

Infliximab Trough Levels Are Associated With Mucosal Healing During Maintenance Treatment With Infliximab in Paediatric Crohn’s Disease
Journal of Crohn's and Colitis. 2018;13(2):189-197   Crossref logo
Link1

Subtherapeutic Infliximab Trough Levels and Complete Mucosal Healing Are Associated With Sustained Clinical Remission After Infliximab Cessation in Paediatric-onset Crohn’s Disease Patients Treated With Combined Immunosuppressive Therapy
Journal of Crohn's and Colitis. 2018;12(6):644-652   Crossref logo
Link1

Quality of life: a potentially useful measure to indicate subclinical flares in Crohn disease
Internal Medicine Journal. 2012;42(7):e145-e151   Crossref logo
Link1

Infliximab/methotrexate
Reactions Weekly. 2018;1712(1):286-286   Crossref logo
Link1 Link2 Link3

Mo1263 CRP, but Not CDAI is Associated With Enterocolonic Mucosal Healing in Crohn's Disease Treated With Infliximab; A Single Center Cohort Study
Gastrointestinal Endoscopy. 2012;75(4):AB369   Crossref logo
Link1 Link2

Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study
Alimentary Pharmacology & Therapeutics. 2018;47(7):906-912   Crossref logo
Link1 Link2

495 Therapeutic Drug Monitoring of Infliximab and Mucosal Healing in Inflammatory Bowel Disease: A Prospective Study
Gastroenterology. 2013;144(5):S-92   Crossref logo
Link1 Link2